ClinicalTrials.gg
Status unknownNCT05398328OrthoPersUpdated Dec 29, 2023

Effect of Personality Traits on Reporting Outcomes of Orthodontic Treatment

A Phase 3 interventional study of active metal appliance and active esthetic appliance in Malocclusion, sponsored by University of Rijeka. Status unknown at 1 site in Croatia. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-12-29.

Sponsored by University of Rijeka · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2023), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2021, registered May 2022).
Phase
Phase 3
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
All
01

Study summary

The study will monitor changes induced by orthodontic treatment and in the retention period, two years after the end of orthodontic treatment. The alignment of teeth, hygiene and gingiva will be assessed. Efficiency of two types of fixed appliances in active phase will be compared - esthetic and metal. Efficiency of two types of retention appliances in retention phase will be compared - fixed and removable.

The benefits of orthodontic treatment to be studied are aesthetic concerns, dental self-confidence, self-esteem, social contacts, psychological influences, and chewing limitation. The stability of personality traits, body image and perfectionism will also be analyzed, as well as the extent to which these dimensions modify the reporting of psychosocial effects of malocclusion treatment.

Read the detailed description

The aim is to analyze:

  1. the extent to which the type of device (metal / aesthetic) affects changes in quality of life (QoL)
  2. whether the change in QoL is influenced by personality traits during therapy
  3. long-term change in QoL and personality traits (before therapy, during, at the end and in retention for 2 years)
  4. whether long-term QoL change is influenced by personality traits
  5. dependence of relapse (incidence and intensity) on the type of retention appliance
  6. change in QoL and personality trait depending on relapse
  7. whether the change in QoL due to relapse is influenced by personality traits
02

Conditions studied

  • Malocclusion

Browse trials for

Keywords

  • malocclusion
  • personality trait
  • quality of life
03

In context

Malocclusion

469 studies on the registry are indexed under Malocclusion; 91 are open to participants now.

This study's planned enrollment of 120 is above the median of 36 across 383 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

University of Rijeka is the lead sponsor of 21 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- malocclusion with moderate or great need for orthodontic treatment (Index of Orthodontic Treatment Need grades >=3)

Exclusion criteria

Exclusion Criteria:

- neurodevelopmental disorders, intellectual disability, oligodontia, congenital craniofacial anomalies, orofacial clefts

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    metal appliance + fixed retainer

    fixed metal appliance MBT 0.022'' slot in active phase followed by bonded wire retainer

    Device: active metal appliance · Combination Product: retention fixed appliance

  • Experimental
    esthetic appliance + fixed retainer

    fixed ceramic appliance MBT 0.022'' slot in active phase followed by bonded wire retainer

    Device: active esthetic appliance · Combination Product: retention fixed appliance

  • Active comparator
    metal appliance + removable retainer

    fixed metal appliance MBT 0.022'' slot followed by removable clear termoplastic retainer

    Device: active metal appliance · Combination Product: retention removable appliance

  • Experimental
    esthetic appliance + removable retainer

    fixed ceramic appliance MBT 0.022'' slot followed by removable clear termoplastic retainer

    Device: active esthetic appliance · Combination Product: retention removable appliance

Interventions

  • Deviceactive metal appliance

    fixed metal labial orthodontic appliance MBT 0.022'' slot

  • Deviceactive esthetic appliance

    fixed ceramic labial orthodontic appliance MBT 0.022'' slot

  • Combination productretention fixed appliance

    fixed lingual metal retention appliance

  • Combination productretention removable appliance

    removable clear termoplastic retention appliance

06

What researchers measure

Primary outcomes

  1. irregularity of teeth

    Little Irregularity Index - sum of displacement of contact points of frontal teeth (range 0-10 mm), higher score mean worse outcome

    Time frame: 48 months (start, 3 months, 1 year, 2 years, 1 year retention, 2 years retention)

  2. patient reported impacts of malocclusion

    Malocclusion Impact Questionnaire with 17 aspects, each on 3-point scale (summary score on scale 0-51), higher score mean worse outcome

    Time frame: 48 months (start, 3 months, 1 year, 2 years, 1 year retention, 2 years retention)

  3. big five personality traits

    Big Five Inventory with 44 statements, each on 5-point scale, grouped into 5 traits: (extroversion (range 8-40), agreeableness (range 9-45), openness (range 10-50), conscientiousness (range 9-45) and neuroticism (range 8-40). higher score mean worse outcome

    Time frame: 48 months (start, end of treatment, 1 year retention, 2 years retention)

Secondary outcomes

  1. normative orthodontic treatment need

    clinically assessed by using Index of Orthodontic Treatment Need - Dental Health Component with 5 grades, range 1=no/minor need - 5=very great need

    Time frame: 48 months (start, end of treatment, 1 year retention, 2 years retention)

  2. esthetic treatment need

    assessed by using Index of Orthodontic Treatment Need - Aesthetic Component with 10 grades, range 1=no need - 10=very great need

    Time frame: 48 months (start, end of treatment, 1 year retention, 2 years retention)

  3. retainer failure

    number of railures of retainer in retention phase, nigher number indicates worse outcome

    Time frame: 24 months

  4. limitations of jaw function

    Jaw Function Limitation Scale with 6 items on 11-point scale (0=no limitation-10=extreme limitation), average score, higher score indicates worse outcome

    Time frame: 48 months (start, 3 months, 1 year, 2 years, 1 year retention, 2 years retention)

  5. self-esteem

    Rosenberg Self-Esteem Scale with 10 items on 5-point scale (1=not at all-5=very much), summary score on scale 5-50, higher score indicates better outcome

    Time frame: 48 months (start, 3 months, 1 year, 2 years, 1 year retention, 2 years retention)

  6. body image

    4 items on 5-point scale (1=not at all-5=very much), total score 4-20, higher score indicates better outcome

    Time frame: 48 months (start, end of treatment, 1 year retention, 2 years retention)

  7. perfectionism

    35 items on 5-point scale (1=completely disagree-5=completely agree), range 29 - 145, higher score indicates better outcome

    Time frame: 48 months (start, end of treatment, 1 year retention, 2 years retention)

  8. psychosocial imapcts of dental esthetics

    23 items on 5-point scale (0=not at all-4=very much), grouped in 4 dimensions - aesthetic concern (range 0-12), dental self-confidence (range 0-24), social influence (range 0-32), psychological influence (range 0-24)), higher score means worse outcome for psychological influence, social influence and aesthetic concern, while in dental self-confidence higher score indicates better outcome

    Time frame: 48 months (start, 3 months, 1 year, 2 years, 1 year retention, 2 years retention)

  9. wite spot lesions of enamel

    number of teeth with enamel defects, scale 0-32, higher number means worse outcome

    Time frame: 48 months (start, 3 months, 2 years, 1 year retention, 2 years retention)

  10. oral hygiene

    Silness-Loe index and Williams modification for subjects in orthodontic treatment on a scale from 0=no biofilm to 3=a continuous line greater than 1mm, mean of all measurement site is used, range 0-3, higher score means worse outcome

    Time frame: 48 months (start, 3 months, 2 years, 1 year retention, 2 years retention)

  11. extent of gingivitis

    Full Mouth Bleeding Score on a scale 0-100%, higher percentage means worse outcome

    Time frame: 48 months (start, 3 months, 2 years, 1 year retention, 2 years retention)

  12. gingival enlargement

    Seymour index (thickness (scale 0=normal-2=thickening \>=3mm) + proportion of tooth crown coverage (scale 0=normal-3=papilla involving .2/3 of adjacent tooth crown half) on frontal teeth vestibular and oral in both jaws; scale 0-100), higher score means worse outcome

    Time frame: 48 months (start, 3 months, 2 years, 1 year retention, 2 years retention)

07

Study locations

1 site
  • University of Rijeka, Faculty of Dental Medicine
    Rijeka, 51000, Croatia
08

References and documents

Individual participant data

Plan to share: Yes — Data obtained through this research may be provided to qualified researchers with academic interest in orthodontic treatment. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis

Access criteria: Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact princial investigator Stjepan Spalj.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2021 (actual). Primary completion is estimated for Jan 2026, 50 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2022
First posted
May 31, 2022
StartActual
Nov 1, 2021
Primary completionEst.
Jan 1, 2026
CompletionEst.
Mar 1, 2026
Last update
Dec 29, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05398328
Lead sponsor
University of Rijeka
Responsible party
Stjepan Spalj (Professor, University of Rijeka) — Principal investigator
First posted
May 31, 2022
Start date
Nov 1, 2021
Primary completion
Jan 1, 2026 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Dec 29, 2023

Study contacts

Stjepan Spalj, PhD
principal investigator · Sveuciliste u Rijeci

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion